Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by Sid123on Sep 04, 2020 8:24pm
316 Views
Post# 31514649

Retail Perspective

Retail Perspective I know everyone is frustrated with MJ SP across the board. The hype pre legalization put valuations unattainable in the short term. I just received AGLC order form for my stores and APHA has brand new products from vapes, flower and PR. Simon Irwin deserves a fair opportunity. SH could do at lot worse like Terry Booth or Hexo or Cann trust. I know there was slick Vic but let's see if Irwin can put APHA into top spot 
 
<< Previous
Bullboard Posts
Next >>